Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stange

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Artificial Organs|September 1, 1993
Dialysis against a recycled albumin solution enables the removal of albumin-bound toxinsJ Stange, W Ramlow, S Mitzner, et al.
Transplantation Proceedings|December 23, 2008
Prolonged survival of renal allograft in rats by methotrexate-albumin conjugates as immunosuppressive therapyH Hickstein, D Wolff, J Stange, et al.
Current Opinion in Nephrology and Hypertension|November 14, 2001
Albumin dialysis using the molecular adsorbent recirculating systemS R Mitzner, J Stange, S Klammt, et al.
Liver|September 11, 2002
Amino acid dysbalance in liver failure is favourably influenced by recirculating albumin dialysis (MARS)J Loock, S R Mitzner, E Peters, et al.
Clinical Nephrology|November 19, 2010
Atypical electrolyte kinetics during an emergency dialysis session in a patient with Leriche syndromeS Koball, H Hickstein, A Führer, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1993
A new procedure for the removal of protein bound drugs and toxinsJ Stange, S Mitzner, W Ramlow, et al.
Liver|September 11, 2002
Albumin dialysis: single pass vs. recirculation (MARS)P Peszynski, S Klammt, E Peters, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|April 16, 2005
[Extracorporeal blood purification in severe liver failure with the albumin dialysis MARS -- impact on relevant intensive care parameters]S Mitzner, S Klammt, J Stange, et al.
Liver|September 11, 2002
Extracorporeal liver support by recirculating albumin dialysis: analysing the effect of the first clinically used generation of the MARSystemS Klammt, J Stange, S R Mitzner, et al.
Artificial Organs|March 7, 2002
MTS colorimetric assay in combination with a live-dead assay for testing encapsulated L929 fibroblasts in alginate poly-L-lysine microcapsules in vitroC M Bünger, A Jahnke, J Stange, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Artificial Organs|September 1, 1993
Dialysis against a recycled albumin solution enables the removal of albumin-bound toxinsJ Stange, W Ramlow, S Mitzner, et al.
Transplantation Proceedings|December 23, 2008
Prolonged survival of renal allograft in rats by methotrexate-albumin conjugates as immunosuppressive therapyH Hickstein, D Wolff, J Stange, et al.
Current Opinion in Nephrology and Hypertension|November 14, 2001
Albumin dialysis using the molecular adsorbent recirculating systemS R Mitzner, J Stange, S Klammt, et al.
Liver|September 11, 2002
Amino acid dysbalance in liver failure is favourably influenced by recirculating albumin dialysis (MARS)J Loock, S R Mitzner, E Peters, et al.
Clinical Nephrology|November 19, 2010
Atypical electrolyte kinetics during an emergency dialysis session in a patient with Leriche syndromeS Koball, H Hickstein, A Führer, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1993
A new procedure for the removal of protein bound drugs and toxinsJ Stange, S Mitzner, W Ramlow, et al.
Liver|September 11, 2002
Albumin dialysis: single pass vs. recirculation (MARS)P Peszynski, S Klammt, E Peters, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|April 16, 2005
[Extracorporeal blood purification in severe liver failure with the albumin dialysis MARS -- impact on relevant intensive care parameters]S Mitzner, S Klammt, J Stange, et al.
Liver|September 11, 2002
Extracorporeal liver support by recirculating albumin dialysis: analysing the effect of the first clinically used generation of the MARSystemS Klammt, J Stange, S R Mitzner, et al.
Artificial Organs|March 7, 2002
MTS colorimetric assay in combination with a live-dead assay for testing encapsulated L929 fibroblasts in alginate poly-L-lysine microcapsules in vitroC M Bünger, A Jahnke, J Stange, et al.
Pageof 5